Aberdeen Group’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-23,735	Closed	-$291K	–	1045
2021 Q1	$291K	Buy	23,735 +8,486	+56%	+$104K	﹤0.01%	957
2020 Q4	$114K	Buy	+15,249	New	+$114K	﹤0.01%	952